跳至主要内容
临床试验/EUCTR2012-003409-86-BE
EUCTR2012-003409-86-BE进行中(未招募)1 期

The effect of naloxone and methylnaltrexone on oesophageal sensitivity in healthy volunteers: a randomized, double-blind placebo controlled study.

KULeuven0 个研究点目标入组 12 人开始时间: 2012年8月30日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Age >18 and <60 years
  • 2. No history of GI disorders or symptoms
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 10
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. A history of allergic reaction to naloxon or methylnaltrexone or multiple allergies to several foods and drugs.
  • 2. Pregnancy and/or lactation
  • 3. Concomittant administration of monomine oxidase inhibitors, verapamil, or diltiazem or medications affecting oesophageal motility
  • 4. Significant co-morbidities (neuro-muscular, psychiatric, cardiovascular, pulmonary, endocrine, auto-immune, renal and hepatic)

研究者

发起方
KULeuven

相似试验

The effect of medication to reduce opioid adverse... | 临床试验